Nada Zendaoui
Nada Zendaoui has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Nardjes Bouchemal
Department of Computer Science, University of Mila, Mila 43000, Algeria
3 shared publications - Naila Bouchemal
LyRIDS ECE Ecole d’Ingénieurs de Paris, 75015 Paris, France
2 shared publications - Galina Ivanova
Faculty of Electrical Engineering, Electronics and Automation, University of Ruse “Angel Kanchev”, 7017 Ruse, Bulgaria
1 shared publication - Imane Boussebough
LIRE Laboratory, Abdelhamid Mehri Constantine 2 University, Constantine 25000, Algeria
1 shared publication - Maya Souilah Benabdelhafid
School of Accounting and Finance ESCF, Constantine LIRE Laboratory of Constantine 2
1 shared publication - Mohamed Rafik Aymene Berkani
Research Laboratory in Advanced Electronics Systems (LSEA) University Yahia Fares of Medea Medea, Algeria, Algeria
1 shared publication
Latest Publications
- Open Access
- 26 October 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (21) , 11433
NS-Assist: Nephrotic Syndrome Assistance System for Pediatric Decision-Making in Pandemic Situations
The COVID-19 pandemic has underscored the need for telemedicine to ensure continuity of pediatric care during health emergencies. This paper presents NS-Assist, a hybrid web–mobile decision support system for managing Idiopathic Nephrotic Syndrome (INS) in children. The system combines rule-based reasoning and fuzzy inference to assist clinicians in diagnosis, treatment adjustment, and relapse monitoring, while enabling caregivers to record and track daily health data. Implemented using Spring Boot, ReactJS, and Flutter with a secure MySQL database, NS-Assist integrates medical expertise with computational intelligence to support remote decision-making. A pilot evaluation involving 40 participants, including clinicians and caregivers, showed improved communication, reduced consultation time, and enhanced follow-up continuity. These results highlight the system’s potential as a reliable and adaptable framework for pediatric telemedicine in resource-constrained and emergency settings.
- 26 October 2025
- Published by MDPI AG in Applied Sciences
- Vol. 15 (21) , 11433
Open AccessNS-Assist: Nephrotic Syndrome Assistance System for Pediatric Decision-Making in Pandemic Situations
The COVID-19 pandemic has underscored the need for telemedicine to ensure continuity of pediatric care during health emergencies. This paper presents NS-Assist, a hybrid web–mobile decision support system for managing Idiopathic Nephrotic Syndrome (INS) in children. The system combines rule-based reasoning and fuzzy inference to assist clinicians in diagnosis, treatment adjustment, and relapse monitoring, while enabling caregivers to record and track daily health data. Implemented using Spring Boot, ReactJS, and Flutter with a secure MySQL database, NS-Assist integrates medical expertise with computational intelligence to support remote decision-making. A pilot evaluation involving 40 participants, including clinicians and caregivers, showed improved communication, reduced consultation time, and enhanced follow-up continuity. These results highlight the system’s potential as a reliable and adaptable framework for pediatric telemedicine in resource-constrained and emergency settings.
- Open Access
- 21 October 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (10) , 1127
AI-RiskX: An Explainable Deep Learning Approach for Identifying At-Risk Patients During Pandemics
Pandemics place extraordinary pressure on healthcare systems, particularly in identifying and prioritizing high-risk groups such as the elderly, pregnant women, and individuals with chronic diseases. Existing Artificial Intelligence models often fall short, focusing on single diseases, lacking interpretability, and overlooking patient-specific vulnerabilities. To address these gaps, we propose an Explainable Deep Learning approach for identifying at-risk patients during pandemics (AI-RiskX). AI-RiskX performs risk classification of patients diagnosed with COVID-19 or related infections to support timely intervention and resource allocation. Unlike previous models, AI-RiskX integrates five public datasets (asthma, diabetes, heart, kidney, and thyroid), employs the Synthetic Minority Over-sampling Technique (SMOTE) for class balancing, and uses a hybrid convolutional neural network–long short-term memory model (CNN–LSTM) for robust disease classification. SHAP (SHapley Additive exPlanations) enables both individual and population-level interpretability, while a post-prediction rule-based module stratifies patients by age and pregnancy status. Achieving 98.78% accuracy, AI-RiskX offers a scalable, interpretable solution for equitable classification and decision support in public health emergencies.
- 21 October 2025
- Published by MDPI AG in Bioengineering
- Vol. 12 (10) , 1127
Open AccessAI-RiskX: An Explainable Deep Learning Approach for Identifying At-Risk Patients During Pandemics
Pandemics place extraordinary pressure on healthcare systems, particularly in identifying and prioritizing high-risk groups such as the elderly, pregnant women, and individuals with chronic diseases. Existing Artificial Intelligence models often fall short, focusing on single diseases, lacking interpretability, and overlooking patient-specific vulnerabilities. To address these gaps, we propose an Explainable Deep Learning approach for identifying at-risk patients during pandemics (AI-RiskX). AI-RiskX performs risk classification of patients diagnosed with COVID-19 or related infections to support timely intervention and resource allocation. Unlike previous models, AI-RiskX integrates five public datasets (asthma, diabetes, heart, kidney, and thyroid), employs the Synthetic Minority Over-sampling Technique (SMOTE) for class balancing, and uses a hybrid convolutional neural network–long short-term memory model (CNN–LSTM) for robust disease classification. SHAP (SHapley Additive exPlanations) enables both individual and population-level interpretability, while a post-prediction rule-based module stratifies patients by age and pregnancy status. Achieving 98.78% accuracy, AI-RiskX offers a scalable, interpretable solution for equitable classification and decision support in public health emergencies.
- 22 December 2023
- Published by Springer Nature
- p. 272-285
AI-LMS: AI-Based Long-Term Monitoring System for Patients in Pandemics: COVID-19 Case Study
- 22 December 2023
- Published by Springer Nature
- p. 272-285
AI-LMS: AI-Based Long-Term Monitoring System for Patients in Pandemics: COVID-19 Case Study